Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$11,872,757
+$612,290 QoQ
Shares Held
92,395
-1.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#688
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Linscomb Wealth, Inc. holds $62,600,297 across 7 Drug Manufacturers - General names. MRK ranks #3 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,722 | $17,796,484 | |
| 2 | JNJ |
Johnson & Johnson
|
59,468 | $15,103,087 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
92,395 | $11,872,757 | |
| 4 | AMGN |
Amgen Inc
|
29,620 | $10,725,994 | |
| 5 | PFE |
Pfizer Inc
|
209,174 | $5,036,909 | |
| 6 | LLY |
ELI LILLY & Co
|
1,056 | $1,266,598 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,320 | $798,468 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,872,757 | 92,395 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $11,260,467 | 93,611 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,456,814 | 108,843 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $8,954,575 | 106,691 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $8,107,092 | 102,414 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $9,132,451 | 101,743 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,712,187 | 77,525 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $8,108,751 | 71,405 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $8,856,652 | 71,540 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $9,399,194 | 71,233 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,724,939 | 70,858 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,408,179 | 71,959 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $8,824,450 | 76,475 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $8,287,781 | 77,900 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,445,181 | 76,117 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,996,191 | 69,626 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,024,969 | 66,085 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,666,675 | 56,876 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,934,315 | 38,287 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,804,982 | 37,345 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,947,327 | 37,898 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,079,284 | 39,944 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,226,763 | 39,447 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,316,176 | 39,978 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,180,738 | 41,132 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,141,920 | 40,836 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||